Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ogsiveo. Always confirm against the full prescribing information.
100 interactions
Abatacept
The metabolism of Nirogacestat can be increased when combined with Abatacept.
Level 1 evidence
Abiraterone
The metabolism of Nirogacestat can be decreased when combined with Abiraterone.
Level 1 evidence
Abrocitinib
The serum concentration of Nirogacestat can be increased when it is combined with Abrocitinib.
Level 2 evidence
Acebutolol
The metabolism of Nirogacestat can be decreased when combined with Acebutolol.
Level 2 evidence
Acoramidis
The metabolism of Nirogacestat can be decreased when combined with Acoramidis.
Level 2 evidence
Adagrasib
The serum concentration of Nirogacestat can be increased when it is combined with Adagrasib.
Level 2 evidence
Adalimumab
The metabolism of Nirogacestat can be increased when combined with Adalimumab.
Level 1 evidence
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Nirogacestat.
Level 2 evidence
Aficamten
The metabolism of Aficamten can be decreased when combined with Nirogacestat.
Level 2 evidence
Albendazole
The metabolism of Nirogacestat can be decreased when combined with Albendazole.
Level 2 evidence
Almasilate
The serum concentration of Nirogacestat can be decreased when it is combined with Almasilate.
Level 1 evidence
Almotriptan
The metabolism of Almotriptan can be increased when combined with Nirogacestat.
Level 2 evidence
Enter your NPI to unlock 14 major interactions for Ogsiveo
Ogsiveo (Nirogacestat) has 658 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Ogsiveo (Nirogacestat) has 69 major, 483 moderate, and 106 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ogsiveo. Always confirm against the full prescribing information.